COLE ANDREW

SEC source: 0001570585-23-000256 · wk-form4_1687294123.xml · nonDerivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,087

SEC source: 0001570585-23-000246 · wk-form4_1686946978.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,945

Underlying: Class C Ordinary Shares · 9,945 shares

Expires 2033-06-14

F3 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2024 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-23-000246 · wk-form4_1686946978.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,973

Underlying: Class A Ordinary Shares · 4,973 shares

Expires 2033-06-14

F3 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2024 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-23-000246 · wk-form4_1686946978.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,726

Underlying: Class C Ordinary Shares · 3,726 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2024 annual general meeting of shareholders.

F2 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2024 annual general meeting of shareholders.

SEC source: 0001570585-23-000246 · wk-form4_1686946978.xml · derivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,863

Underlying: Class A Ordinary Shares · 1,863 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2024 annual general meeting of shareholders.

F2 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2024 annual general meeting of shareholders.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 12

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,882

Underlying: Class C Ordinary Shares · 15,882 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 11

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 15,882 shares

Expires 2025-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 10

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,300

Underlying: Class C Ordinary Shares · 14,300 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 9

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 14,300 shares

Expires 2024-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 8

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,680

Underlying: Class C Ordinary Shares · 11,680 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 7

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 11,680 shares

Expires 2023-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 6

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,941

Underlying: Class A Ordinary Shares · 7,941 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 5

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 7,941 shares

Expires 2025-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,150

Underlying: Class A Ordinary Shares · 7,150 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 7,150 shares

Expires 2024-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,840

Underlying: Class A Ordinary Shares · 5,840 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-23-000138 · wf-form4_168262923323574.xml · derivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 5,840 shares

Expires 2023-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 12

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,823

Underlying: Class C Common Shares · 8,823 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 11

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 8,823 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 10

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,150

Underlying: Class C Common Shares · 7,150 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 9

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 7,150 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 8

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,840

Underlying: Class C Common Shares · 5,840 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 7

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Common Shares · 5,840 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 6

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,412

Underlying: Class A Common Shares · 4,412 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 5

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 4,412 shares

Expires 2028-06-12

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,575

Underlying: Class A Common Shares · 3,575 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 3,575 shares

Expires 2027-06-21

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,920

Underlying: Class A Common Shares · 2,920 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-24-000064 · wk-form4a_1709591350.xml · derivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Shares · 2,920 shares

Expires 2026-06-16

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F3 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

F2 · derivative.underlying_shares: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

F2 · balance_after: This amendment is being filed solely to amend the number of derivative securities with respect to these transactions because the Form 4 filed by the Reporting Person on April 27, 2023 inadvertently did not reflect that on May 23, 2021, the Reporting Person became obligated to transfer half his share options (which for the purposes of the derivative securities reported here are: 2,920 Share Option A expiring on June 16, 2026; 3,575 Share Option A expiring on June 21, 2027; 3,529 Share Option A expiring on June 12, 2028; 5,840 Share Option C expiring on June 16, 2026; 7,150 Share Option C expiring on June 21, 2027; and 7,059 Share Option C expiring on June 12, 2028) to his ex-spouse pursuant to a domestic relations order.

SEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,437

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

SEC source: 0001570585-23-000107 · wf-form4_168064511212091.xml · nonDerivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,374

F1 · shares: Acquired in accordance with the terms of the Liberty Global 2014 Nonemployee Director Incentive Plan for the equity portion of the fees paid to the Reporting Person for his services as a director. The number of shares was determined using the closing market price of the applicable class of ordinary shares on March 31, 2023.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · derivative · entry 7

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 2,247 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F3 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

F3 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · derivative · entry 6

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 1,124 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F3 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

F3 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · derivative · entry 5

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,861

Underlying: Class C Ordinary Shares · 13,861 shares

Expires 2032-06-15

F2 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2023 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,931

Underlying: Class A Ordinary Shares · 6,931 shares

Expires 2032-06-15

F2 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2023 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · nonDerivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-22-000183 · wf-form4_165550116343411.xml · nonDerivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,105

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

SEC source: 0001570585-24-000063 · wk-form4a_1709591324.xml · nonDerivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · balance_after: This amendment is being filed solely to amend the amount of securities reported as beneficially owned following this transaction. The Form 4 filed by the Reporting Person on June 17, 2022 (the "Original Report") inadvertently did not reflect that on May 8, 2021, the Reporting Person transferred 11,490 Class A Ordinary Shares and 28,325 Class C Ordinary Shares to his ex-spouse pursuant to a domestic relations order. This amendment to the Original Report is deemed to amend the Form 4s filed after the Original Report and prior to the date of this amendment with respect to the amount of securities reported as beneficially owned, as applicable, to subtract these transferred shares.

SEC source: 0001570585-24-000063 · wk-form4a_1709591324.xml · nonDerivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · balance_after: This amendment is being filed solely to amend the amount of securities reported as beneficially owned following this transaction. The Form 4 filed by the Reporting Person on June 17, 2022 (the "Original Report") inadvertently did not reflect that on May 8, 2021, the Reporting Person transferred 11,490 Class A Ordinary Shares and 28,325 Class C Ordinary Shares to his ex-spouse pursuant to a domestic relations order. This amendment to the Original Report is deemed to amend the Form 4s filed after the Original Report and prior to the date of this amendment with respect to the amount of securities reported as beneficially owned, as applicable, to subtract these transferred shares.

SEC source: 0001570585-21-000235 · wf-form4_162431163248902.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,898

Underlying: Class C Ordinary Shares · 6,898 shares

Expires 2031-06-16

F3 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2022 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-21-000235 · wf-form4_162431163248902.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,449

Underlying: Class A Ordinary Shares · 3,449 shares

Expires 2031-06-16

F3 · derivative.exercise_date: The option vests in three equal annual installments commencing on the date of the Issuer's 2022 annual general meeting of shareholders and on the date of each annual general meeting of shareholders thereafter.

SEC source: 0001570585-21-000235 · wf-form4_162431163248902.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,247

Underlying: Class C Ordinary Shares · 2,247 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

F2 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

SEC source: 0001570585-21-000235 · wf-form4_162431163248902.xml · derivative · entry 1

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,124

Underlying: Class A Ordinary Shares · 1,124 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of Issuer's Class A ordinary shares or Class C ordinary shares, as the case may be.

F2 · derivative.exercise_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

F2 · derivative.expiration_date: The Restricted Share Units will vest in full on the date of the Issuer's 2022 annual general meeting of shareholders.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 8

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,548

Underlying: Class C Ordinary Shares · 8,548 shares

Expires 2025-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 7

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 8,548 shares

Expires 2022-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 6

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,303

Underlying: Class A Ordinary Shares · 4,303 shares

Expires 2025-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 5

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Ordinary Shares · 4,303 shares

Expires 2022-06-25

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 4

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,379

Underlying: Class C Ordinary Shares · 11,379 shares

Expires 2024-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 3

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class C Ordinary Shares · 11,379 shares

Expires 2021-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.

SEC source: 0001570585-21-000120 · wf-form4_161852246788270.xml · derivative · entry 2

COLE ANDREW · CIK 0001439731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,716

Underlying: Class A Ordinary Shares · 5,716 shares

Expires 2024-06-26

F1 · kind: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · price: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F1 · derivative.exercise_date: The reported transactions involve an extension of the seven-year exercise period on existing share options for an additional three-year period. For Form 4 reporting purposes, this is shown as if the outstanding option were to be cancelled and replaced by a new option. However, from the Issuer's perspective, no new option is issued, the Issuer has only extended the expiration term on the original grant, with the same pricing and other terms continuing to apply.

F2 · derivative.exercise_date: Vesting and exercise of the existing option has not changed as a result of the extension and therefore the option continues to be immediately exercisable.